As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Aims and scope
EJNMMI Physics is an international platform for scientists, users and adopters of nuclear medicine with a particular interest in physics matters. As a companion journal to the European Journal of Nuclear Medicine and Molecular Imaging, this journal has a multi-disciplinary approach and welcomes original materials and studies with a focus on applied physics and mathematics as well as imaging systems engineering and prototyping in nuclear medicine. This includes physics-driven approaches or algorithms supported by physics that foster early clinical adoption of nuclear medicine imaging and therapy.
EJNMMI Physics publishes original research articles, reviews, case reports, commentaries, and short communications, as well as article types with unique submission criteria, Young Investigator Articles and Teaching Files.
Young Investigator Articles: This category is reserved for young scientists in the course of their MSc or PhD studies who wish to present part of their undergraduate and graduate research in a scientific framework. Manuscripts should follow the structure of an original research submission, however, the content may be comprised of several sub-projects. Typically, young investigator reports entail a scientifically sound summary report of a short-term project or a PhD thesis.
Teaching Files: This category is reserved for manuscripts that aim at educating the readership on an important or common application of physics in nuclear medicine imaging and therapy. To introduce, explain, detail and summarise an observation, process, workflow related to the physics of nuclear medicine or hybrid imaging. The same trail of educational thoughts may be applicable to methodologies and applications of physics in nuclear medicine, e.g. image-guided dosimetry.
COVID-19 and impact on peer review
Radionuclide therapy and molecular radiotherapy are established modalities for treatment of certain cancer types. In recent years there has been a significant expansion of new therapy options, radiopharmaceuticals and applications. Dosimetry is an essential component in the treatment chain to maximize the delivered absorbed dose to cancerous tissue while minimizing the dose to healthy organs. To highlight the rapid changes in this field and to address the remaining challenges, EJNMMI Physics is publishing an article collection on this topic.
Annual Journal Metrics
67 days to first decision for reviewed manuscripts only
61 days to first decision for all manuscripts
146 days from submission to acceptance
20 days from acceptance to publication
59 Altmetric Mentions
Need help with APC funding?
We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here.
Check if your institution is a member
More than 500 institutions have partnered with BMC through the membership program. As an affiliated Author from a member institution, you may be entitled to submit your manuscript without paying the article processing charge (APC) or with a discount. Check here if your institution is a member!
EJNMMI Journal Family
Discover featured content, editor’s highlights, and the latest research via our Gateway to the EJNMMI Journal Family.
EJNMMI Physics aims to publish new research in nuclear medicine physics and related matters. It addresses research in nuclear medicine physics, dosimetry, reconstruction and instrumentation. It welcomes original studies with a focus on applied physics and mathematics as well as imaging systems engineering and prototyping in nuclear medicine. This includes physics-driven approaches or algorithms supported by physics that foster early clinical adoption of nuclear medicine imaging and therapy. The open access model leads to fast distribution and wide distribution of new scientific results. Manuscripts are accepted for publication only after thorough peer review.
This journal has been launched by Springer and is a companion journal to the EJNMMI family. Authors of papers with a focus on nuclear medicine physics, whose manuscript despite high quality is not accepted in the mother journal can submit to this daughter journal. Besides regular papers the journal gives the possibility to publish reviews, educational papers guidelines and short communications.
By this combination of different articles, I hope to establish a unique platform for nuclear medicine physics related research.
Stefaan Vandenberghe, Editor-in-Chief, Ghent University